Synonyms: GSK-2398852 | GSK2398852
Compound class:
Antibody
Comment: Dezamizumab (GSK2398852) is an anti-human serum amyloid P component (anti-SAP) monoclonal antibody, that was developed by GlaxoSmithKline as a potential therapy for the rare disease amyloidosis.
|
Selectivity at other protein targets | ||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||
|